Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study.
Tikk K, Sookthai D, Fortner RT, Johnson T, Rinaldi S, Romieu I, Tj?nneland A, Olsen A, Overvad K, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Masala G, Krogh V, Tumino R, Ricceri F, Mattiello A, Agudo A, Men?ndez V, S?nchez MJ, Amiano P, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, Monninkhof EM, Onland-Moret NC, Andresson A, Sund M, Weiderpass E, Khaw KT, Key TJ, Travis RC, Merritt MA, Riboli E, Dossus L, Kaaks R. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study. Breast Cancer Res. 2015 Mar 31; 17:49.